Outcome | IPFT (n = 40) | Surgical intervention (n = 18) | p-value |
---|---|---|---|
Baseline chest radiography (cm2)—mean | 119.96 ± 56.05 | 78.19 ± 55.6 | 0.026 |
Duration from baseline chest radiography to intervention (days)—median (IQR) | 2.0 (1–11) | 3.5 (1–32) | 0.12 |
Week 1a | |||
Chest radiograph changes (%)—mean | 31.68 ± 36.37 | 32.05 ± 33.24 | 0.976 |
Success rate (n) | 8 (27%) | 2 (20%) | 1.000 |
Week 4–8b | |||
Chest radiograph changes (%)- median (IQR) | 49.8 (− 123.48–100) | 73.46 (45.79–100) | 0.054 |
Success rate (n) | 15 (56%) | 8 (80%) | 0.26 |
Pre-intervention total white cells (× 109/L)–median (IQR) | 10.4 (4.1–60.4) | 9.75 (6.9–18.8) | 0.545 |
48 h post-intervention total white cells (× 109/L)—median (IQR) | 12.15 (5.4–84.8) | 11.1 (4.5–22.8) | 0.656 |
pre-intervention CRP (mg/dL)—median (IQR) | 9.64 (0.48–33.2) | 9.48 (0.48–43.59) | 0.808 |
48 h post-intervention CRP (mg/dL)—median (IQR) | 10.41 (0.77–25.45) | 6.41 (2.58–31.84) | 0.664 |
Duration of a chest tube in situ (days)—median (IQR) | 14 (3–193) | 13.5 (8.5–19.75) | 0.686 |
Length of stay (days)—median (IQR) | 21.5 (3–73) | 26.5 (7–68) | 0.068 |
Mortality at 30Â days (n) | 2 (5%) | 0 (0%) | 0.587 |
Immediate post-intervention complicationsc (n) | 11 (27.5%) | 17 (94%) |  < 0.0005 |
 Hypotension | 0 | 16 | |
 Bleeding | 2 | 1 | |
 Fever | 6 | 0 | |
 Chest pain | 3 | 0 |